Related Experiment Videos
Methicillin resistant Staphylococcus aureus in patients undergoing major amputation.
S A Grimble1, T R Magee, R B Galland
1Department of Surgery, Royal Berkshire Hospital, Reading, UK.
Summary
Major amputation patients with MRSA infection face significantly higher mortality and delayed wound healing. Prophylactic antibiotics against MRSA are recommended for these high-risk surgical cases.
Area of Science:
- Medical Microbiology
- Infectious Diseases
- Surgical Outcomes
Background:
- Methicillin-resistant Staphylococcus aureus (MRSA) poses a significant threat in healthcare settings.
- The impact of MRSA infection on patients undergoing major amputation requires thorough investigation.
Purpose of the Study:
- To evaluate the outcomes of major amputation in patients with and without MRSA infection.
- To determine the specific effects of MRSA on mortality, wound healing, and complication rates.
Main Methods:
- Retrospective cohort study comparing MRSA-positive and MRSA-negative patients undergoing major amputation.
- Data collected from January 1995 to December 1999 at a District General Hospital.
- Outcomes assessed included mortality, wound healing, and infection rates.
Main Results:
- MRSA was present in 21% of patients undergoing amputation.
- MRSA-positive patients exhibited significantly higher mortality (43% vs. 9%) and lower rates of primary wound healing (24% vs. 57%).
- Delayed healing and chronic infection were more prevalent in MRSA-positive cases.
Conclusions:
- MRSA infection is associated with substantially increased morbidity and mortality following major amputation.
- Consideration of specific antibiotic prophylaxis targeting MRSA is warranted for patients undergoing major amputation to mitigate these risks.